Join our mailing list and receive the monthly BioVox newsletter for free!

RELATED ARTICLES
The Center of Human Genetics reveals all your secrets

Have a cystic fibrosis or BRCA mutation, or maybe a dangerous variant of the Huntington’s gene  dangling in your cells? The Center of Human Geneti…


Idylla™ : a lab-in-a-box

Janssen and Biocartis are collaborating in order to bring diagnostic  testing closer to the patients. To learn more about the future objectives of…


Biocartis takes on lung cancer

Biocartis ups its arsenal once again. This time, the company behind the diagnostic Idylla™ platform adds a lung cancer assay to its ever growing m…

POPULAR TAGS

Multiplicom launches non-invasive test to detect Down's

Written by DS on in the category news with the tags , .


Multiplicom (Niel) launched a new non-invasive prenatal test (NIPT), Clarigo™, based on a blood sample. Genetic analysis of the baby’s DNA, which is present in the blood of the mother, enables the detection of Down’s syndrome (trisomy 21), Edwards’ syndrome (trisomy 18) and Patau syndrome (trisomy 13). This test can be performed as early as 8 weeks into pregnancy.

Thanks to the increased sensitivity and reliability of this test compared to the current test to detect trisomy, a large number of pregnant women will be spared from the invasive amniocentesis procedure. If a genetic abnormality is found, the pregnant woman will be referred to the classic invasive procedure to confirm the result.

Multiplicom hopes to include the test in the current prenatal testing program for pregnant women. “The test will provide much greater reassurance and comfort during pregnancy,” says Dirk Pollet, CEO of Multiplicom.

Read more about: , .

RELATED ARTICLES
The Center of Human Genetics reveals all your secrets

Have a cystic fibrosis or BRCA mutation, or maybe a dangerous variant of the Huntington’s gene  dangling in your cells? The Center of Human Geneti…


Idylla™ : a lab-in-a-box

Janssen and Biocartis are collaborating in order to bring diagnostic  testing closer to the patients. To learn more about the future objectives of…


Biocartis takes on lung cancer

Biocartis ups its arsenal once again. This time, the company behind the diagnostic Idylla™ platform adds a lung cancer assay to its ever growing m…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

KU Leuven UGent XpandInnovation Turnstone Itera Life Science Flanders.bio Janssen Biowin GSK V-Bio Ventures

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.